Diagnosis and management of complement mediated thrombotic microangiopathies.
about
Transplant-associated thrombotic microangiopathy: opening Pandora's box.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.Diagnosis of atypical hemolytic uremic syndrome and response to eculizumab therapy.Complement regulators in human disease: lessons from modern genetics.Modified Ham test for atypical hemolytic uremic syndromeADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic SyndromeDirect evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls.Atypical Hemolytic Uremic Syndrome: A Brief Review.Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura.Complementopathies.Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways.Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.The role of von Willebrand factor in thrombotic microangiopathy.An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment
P2860
Q30235311-B7E8513C-F222-4686-BC54-70A1154E8C8BQ30276550-1EA50532-B1E0-40E7-8B82-6DE91270BE16Q33416047-8C54C2D2-9C88-453E-AAB8-33D381FEF52FQ33417999-EECE1B3E-2797-4F29-8DA3-B5BA056DFCA5Q33419261-E796F861-AB5E-4894-B1C7-AD29FCCBA766Q33421884-56AA0B9A-4178-4D3F-B10B-24109595A7A0Q33425651-6A2B0A19-1A6D-434F-8A09-ADABCEE9B231Q33427460-E9BFDE5E-E73A-40BD-9E90-AB0C3CF12A60Q33430320-9639411F-24D1-4AFC-B23A-7B40847CE726Q33436512-16448011-D175-4209-BC7E-234ACA691335Q33437488-AD0DA18D-01B3-4FDE-A608-BB65EBBB44E1Q33439434-14EC12CC-1B5E-4917-8739-A94C8A53CE29Q33442794-34E95604-693D-4CB8-B9A9-6787C8AC800FQ36668789-79BD565E-CBFC-4F92-B535-DCBC4DDFF2DAQ39142842-53A9CFE2-0C50-4F09-92D6-ACE7CE250914Q47108030-AFFCD11A-7D1C-4DC2-AA56-2F6F3438AA85Q48207019-6FC2AD2E-08C1-4779-B8FC-FAA3D90BDA8DQ48338971-32019986-F25A-4888-8536-5E6D177333FBQ57821657-1298B190-4C46-442C-A34F-7601900678C9
P2860
Diagnosis and management of complement mediated thrombotic microangiopathies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diagnosis and management of complement mediated thrombotic microangiopathies.
@ast
Diagnosis and management of complement mediated thrombotic microangiopathies.
@en
type
label
Diagnosis and management of complement mediated thrombotic microangiopathies.
@ast
Diagnosis and management of complement mediated thrombotic microangiopathies.
@en
prefLabel
Diagnosis and management of complement mediated thrombotic microangiopathies.
@ast
Diagnosis and management of complement mediated thrombotic microangiopathies.
@en
P1433
P1476
Diagnosis and management of complement mediated thrombotic microangiopathies.
@en
P2093
Haifeng M Wu
Spero R Cataland
P356
10.1016/J.BLRE.2014.01.003
P577
2014-01-31T00:00:00Z